Will Lewis, CEO and Chair of Insmed, discusses his unique career path and the insights on leadership, flexibility, and intellectual curiosity that shaped his career journey.
Read MoreRodrick Miller, CEO of Invest Puerto Rico, explains Puerto Rico’s unique juxtaposition between the U.S., Latin America’s, and the Caribbean’s financial markets, the size and value of its pharmaceutical industry, and what makes it stand out in terms of resilience in small businesses, startups, and Knowledge Services.
Read MorePablo Lapuerta, the Executive Vice President and Chief Medical Officer of Lexicon Pharmaceuticals, focuses heavily on genetics and drug development. He discusses the messaging that the pharmaceutical industry needs to do in order to help the public understand the extensive processes behind bringing new drugs to market, improvements that could be made in the FDA’s drug approval process, and a novel drug that he and Lexicon have developed to treat Type I diabetes.
Read MoreBusiness Today speaks with Pat Wang, CEO of Healthfirst, which currently collaborates with more than 37,000 providers to provide health services to over 1.36 million New Yorkers. Wang elaborates on her efforts to bring medical access to lower-income and minority communities and the importance of improving medical records databases for accuracy.
Read MoreSenator Bernie Sanders has been one of the most vocal supporters of a single-payer Medicare plan, and he has not shied away from calling out the pharmaceutical industry for driving up drug prices. However, is his approach truly the panacea for the American healthcare crisis?
Read MoreTed Karkus, the CEO of ProPhase Labs, sat down with BT to speak about his career, the pharmaceutical industry, and advice he had for students.
Read MoreNate Massari is the co-founder and managing partner of Rumpus Therapeutics, a company devoted to combining business with research to help contribute towards the development of drugs and medicines targeted specifically at curing diseases in children.
Read MoreFounding member of the Broad Institute speaks on the effect of automation on new bio-technological research
Read MoreMartin Shkreli had a storied business history full of litigation and scandal.
Read More